JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Alexandria Real Estate Equities, Inc. Announces Pricing Of Public Offering Of 6,500,000 Shares Of Common Stock
-
JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
-
Ashford Trust Prices Public Offering Of Preferred Stock
-
Syros Pharmaceuticals Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
-
NHI to Attend the JMP Securities Boston Real Estate Event
-
JMP Securities Downgrades Medical Properties Trust (MPW) to Market Perform
-
Syros Pharmaceuticals (SYRS) IPO Opens Up 20%
-
LTC Senior Management to Participate at the JMP Securities Boston Real Estate Event
-
JMP Securities Resumes AtriCure Inc. (ATRC) at Market Outperform
-
Syros Pharmaceuticals (SYRS) Prices 4M Common Stock IPO at $12.50/Share, Under Expected Range
-
Syros Pharmaceuticals Announces Pricing of Initial Public Offering
-
Hercules Announces the Second Closing of its 6.25% Notes Due 2024 Offering of $60.0 Million
-
JMP Securities Starts Argo Group International (AGII) at Market Perform
-
Sabra Health Care REIT, Inc. Participating in the JMP Securities Boston Real Estate Event
-
Twilio (TWLO) IPO Opens Up 60%
-
Twilio (TWLO) Prices 10M Common Stock IPO at $15/Share, Above Expected Range
-
Hercules Prices an Additional $60.0 Million of 6.25% Notes Due 2024
-
Twilio Announces Pricing of Initial Public Offering
-
JMP Securities Downgrades Qlik Technologies (QLIK) to Market Perform
-
Notable Analyst Rating Changes 6/22: (GFI) (ENLK) (WEN) Upgraded; (HR) (PZZA) (MGP) Downgraded
-
Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
-
JMP Securities Downgrades Healthcare Realty Trust (HR) to Market Underperform
-
JMP Securities Downgrades Physicians Realty Trust (DOC) to Market Perform
-
Medgenics (MDGN) Prices 3.64M Common Stock Offering at $5.50/Share
-
SteadyMed to Present at the 2016 JMP Securities Life Sciences Conference
-
Medgenics Announces Pricing of Public Offering of Common Stock
-
Summit Hotel Properties Prices Public Offering Of 6.45% Series D Cumulative Redeemable Preferred Stock
-
Teligent, Inc. To Present At JMP Securities Life Sciences Conference On June 21, 2016
-
Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
Immune Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016
-
Intrexon to Present at the JMP Securities Life Sciences Conference
-
Mainstay Medical to Present at the 2016 JMP Securities Life Sciences Conference
-
OvaScience to Present at the JMP Securities Life Sciences Conference
-
Tonix Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
JMP Securities Starts Getty Realty (GTY) at Market Perform
-
Corbus Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 22, 2016
-
OticPharma to Present at the 2016 JMP Securities Life Sciences Conference
-
DBV Technologies to Present at the JMP Securities Life Sciences Conference
-
DBV Technologies to Present at the JMP Securities Life Sciences Conference
-
Accera to Present at the JMP Securities Life Science Conference
-
Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference
-
ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016
-
Auris Medical to Present at the JMP Securities Life Sciences Conference on Wednesday, June 22
-
Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference
-
Alzheon to Present at the 2016 JMP Securities Life Sciences Conference
-
ADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference
-
Summit Therapeutics to Present at JMP Securities Life Sciences Conference
-
AxoGen to Present at JMP Securities Healthcare Conference 2016
-
Inotek Pharmaceuticals Announces Participation in Fireside Chat at JMP Securities 2016 Life Sciences Conference
-
Atara Bio to Present at the JMP Securities Life Sciences Conference

